SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g)
of the Securities Exchange Act of 1934 or Suspension of Duty to File
Reports Under Sections 13 and 15(d) of the Securities
Exchange Act of 1934
Commission File Number ------------N/A---------
GENERAL MEDICAL CORPORATION
-----------------------------------------------------
(Exact name of registrant as specified in its charter)
8741 Landmark Road, P.O. Box 27542, Richmond, VA 23261 (804) 897-6000
----------------------------------------------------------------------
(Address, including zip code, and telephone number, including
area code, of registrant's principal executive offices)
12 % Series A Subordinated Pay-in-Kind Debentures due 2005
---------------------------------------------------------
and 10 % Series A Senior Subordinated Notes due 2003
----------------------------------------------------
(Title of each class of securities covered by this Form)
NONE
-------------------------------------------------------------------
(Titles of all other classes of securities for which a duty to file
reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the
appropriate rule provision(s) relied upon to terminate or suspend
the duty to file reports:
Rule 12g-4(a)(1)(i) [ ] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [x ]
Approximate number of holders of record as of the certification
or notice date:
Cede & Co. is the sole record holder of the Company's10 % Series
A Senior Subordinated Notes due 2003 and there are 6 record
holders of the Company's 12 % Series A Subordinated Pay-in-Kind
Debentures due 2005 of which Cede & Co. is one of the record
holders.
Pursuant to the requirements of the Securities Exchange Act
of 1934 General Medical Corporation has caused this
certification/notice to be signed on its behalf by the
undersigned duly authorized person.
DATE: March 17, 1997 BY: /s/ Donald B. Garber
Name: Donald B. Garber
Title: Chief Financial Officer
